FDMT
4D Molecular Therapeutics Inc
14.50$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 234.4% | 130.0% | 554.2% | 389.6% | 16.7% | 124.0% | 468.5% | 381,889.2% | 8.9% | |
| -134.4% | -30.0% | -454.2% | -289.6% | 100.0% | 100.0% | -368.5% | -381,789.2% | 91.1% | |
| 234.4% | 130.0% | 627.8% | 389.6% | 340.2% | 2,564.8% | 468.5% | 381,889.2% | 229.7% | |
| 60.3% | 43.6% | 198.9% | 126.6% | 155.3% | 1,051.7% | 176.1% | 125,889.2% | 57.6% | |
| 294.7% | 173.6% | 272.4% | 126.6% | 495.5% | 3,616.5% | 176.1% | 125,889.2% | 278.3% | |
| -194.7% | -73.6% | -726.7% | -416.3% | -395.5% | -3,516.5% | -544.6% | -507,678.4% | -187.2% | |
| 0.0% | 0.0% | 0.0% | 1.1% | 16.8% | 205.1% | – | – | – | |
| -193.8% | -67.6% | -705.8% | -416.5% | -395.4% | -3,435.4% | -486.6% | -434,778.4% | -164.4% | |
| -1.5% | 6.0% | 52.0% | -1.1% | -16.7% | -205.1% | 26.9% | – | – | |
| -193.8% | -67.6% | -705.8% | -416.5% | -378.6% | -3,230.3% | -486.6% | -434,778.4% | -164.4% | |
| -183.9% | -68.7% | -638.7% | -405.7% | -378.7% | -3,392.5% | -466.3% | -416,656.8% | -155.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.